Red Blood Cell Irradiation, Storage, Metabolomics and Mesenteric Tissue Oxygenation Responses to Transfusion in Very Preterm Infants
Monday, May 1, 2023
8:30 AM – 8:45 AM ET
Location: Convention Center: 150 B
Publication Number: 3125.3
Ravi M. Patel, Children's Healthcare of Atlanta and Emory University, Atlanta, GA, United States; Joshua Lukemire, Emory University, Atlanta, GA, United States; Neeta Shenvi, Emory University, Atlanta, GA, United States; Michael Hinkes, Pediatrix Medical Group, Atlanta, GA, United States; Sean Stowell, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, United States; John Roback, Emory University School of Medicine, Atlanta, GA, United States; Terri Marin, Medical College of Georgia at Augusta University, Augusta, GA, United States; Kirk A. Easley, Emory University, Atlanta, GA, United States; Ying Guo, Emory University, Atlanta, GA, United States; Rishikesan Kamaleswaran, Emory University School of Medicine, Atlanta, GA, United States; Cassandra Josephson, Johns Hopkins University School of Medicine, St. Petersburg, FL, United States
Presenting Author(s)
Ravi M. Patel, MD, MSc (he/him/his)
Associate Professor of Pediatrics Children's Healthcare of Atlanta and Emory University Atlanta, Georgia, United States
Disclosure(s):
Ravi M. Patel, MD, MSc: Infant Bacterial Therapeutics / Premier Research (Ongoing) (Products/Services: Consultant); Medtronic (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Noveome (Ongoing) (Products/Services: Consultant)
Joshua Lukemire, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Neeta Shenvi, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Michael Hinkes, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sean Stowell, MD PhD: Alexion (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Argenx (Ongoing) (Products/Services: Consultant); Cellics (Ongoing) (Products/Services: Consultant); Grifols (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Novartis (Ongoing) (Products/Services: Consultant)
John Roback, MD, PhD: Cambium Medical Technologies (Ongoing) (Products/Services: Consultant, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Secure Transfusion Solutions (Ongoing) (Products/Services: Advisory Committee, Consultant, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds, Speaker Honorarium including speakers bureau, symposia, and expert witness)
Terri Marin, PhD: Educational speaker for Medtronic, Inc. (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness)
Kirk A. Easley, MApStat. MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ying Guo, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rishikesan Kamaleswaran, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Cassandra Josephson, MD: Cellphire (Terminated, November 16, 2022) (Products/Services: Consultant); Medtronics (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Octapharma, LLC (Terminated, November 16, 2022) (Products/Services: Consultant)
